The XBI reached another all-time high on the back of positive data from Abivax, and generally overall positive data and dealmaking in the I&I space. On the downside, Evommune's MRGPRX2 antagonist failed a phase 2b in CSU, and Unicycive fell after receiving another CRL for its hyperphosphatemia application due to CMC issues.
Also look for unique social pages for BiotechTV U.
10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.
Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.
.png){kind=logo}